ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 60.24

Change

-0.65 (-1.07)%

Market Cap

CAD 0.22B

Volume

2.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.33 (+0.86%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

+0.06 (+0.55%)

CAD 1.79B
XIT:CA iShares S&P/TSX Capped Informa..

+1.07 (+1.80%)

CAD 0.82B
TXF:CA First Asset Tech Giants Covere..

+0.08 (+0.47%)

CAD 0.61B
HTA:CA Harvest Tech Achievers Growth ..

+0.05 (+0.32%)

CAD 0.59B
XHC:CA iShares Global Healthcare (CAD..

-0.27 (-0.42%)

CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.04 (+0.18%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.13 (+0.46%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.45 (+0.79%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

+0.14 (+0.79%)

CAD 0.29B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.32% 49% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.32% 49% F 29% F
Trailing 12 Months  
Capital Gain -10.80% 20% F 18% F
Dividend Return 0.72% 26% F 11% F
Total Return -10.07% 14% F 16% F
Trailing 5 Years  
Capital Gain 4.73% 23% F 34% F
Dividend Return 2.89% 21% F 4% F
Total Return 7.62% 11% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain 1.35% 26% F 37% F
Dividend Return 1.77% 14% F 30% F
Total Return 0.42% 26% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 14.06% 66% D+ 58% F
Risk Adjusted Return 12.61% 11% F 28% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.